The key objectives of the MARCE Developmental Research Plan are to test innovative concepts, develop new technologies, and support """"""""high-risk"""""""" opportunities that demonstrate potential for """"""""highyield"""""""" novel results in the broad area of biodefense and emerging infectious diseases research. All applicants for theses Awards will be expected to relate their Developmental Project plans to the over-arching theme of the MARCE, """"""""Emerging pathogen-host interactions"""""""", as well as to one of our Research Programs. In year 1, the MARCE will solicit applications for five Developmental Research Awards in the amount of $120,000 each for 2 years to support the Diagnostics Program (VI). Projects will be encouraged that apply novel technologies through broad-spectrum platforms for the detection of agents or toxins under study in Programs -V. In year 3, Developmental Research Awards projects will be solicited that focus on emergent technologies and novel concepts and that can integrate within any of the 6 Research Programs. An external review committee will assist in the application review process. A structured system to monitor and evaluate the progress of the selected projects will ensure the success of the Plan. Overall, the Developmental Research Plan is anticipated to enhance and support the MARCE Strategic Plan in several ways. First, the addition of new investigators and institutions to MARCE will complement the existing interactions among established MARCE researchers and will inject fresh ideas and new perspectives into the field. Second, the incorporation of these new projects into MARCE will further expand the scope of the research portfolio. Third, the Developmental Research Projects will enhance synergies within the existing Research Programs by serving as bridges to link programmatic project themes and by providing new methodologies that may be applicable to several projects. Ultimately, the investigators who receive these Awards will increase the overall pool of qualified researchers in this field. In addition, the recipients of these Awards will become part of the network of MARCE investigators whose exchange of ideas and expanded areas of collaboration are made possible via direct interaction at MARCE meetings and training events. As was the case during the first funding period, recipients will be encouraged to exploit the preliminary data that they generated through research supported by these Awards into the acquisition of additional competitive grant support. In this way the most successful research projects and promising new technologies can be amplified and extended for the benefit of biodefense and emerging infectious disease research.

Public Health Relevance

The Developmental Research Plan will complement the overall MARCE Program through the addition of new projects that will test innovative concepts, explore new technologies, and support high-risk opportunities that demonstrate potential for high-yield novel results in the broad area of biodefense and emerging infectious diseases research. Scientific information and translational research capacity resulting from this Program will ultimately result in new or improved therapeutic, preventive or diagnostic products for the benefit of public

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54AI057168-07
Application #
8037607
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-03-01
Budget End
2011-02-28
Support Year
7
Fiscal Year
2010
Total Cost
$438,225
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Champion, Anna E; Bandara, Aloka B; Mohapatra, Nrusingh et al. (2018) Further Characterization of the Capsule-Like Complex (CLC) Produced by Francisella tularensis Subspecies tularensis: Protective Efficacy and Similarity to Outer Membrane Vesicles. Front Cell Infect Microbiol 8:182
Bridge, Dacie R; Blum, Faith C; Jang, Sungil et al. (2017) Creation and Initial Characterization of Isogenic Helicobacter pylori CagA EPIYA Variants Reveals Differential Activation of Host Cell Signaling Pathways. Sci Rep 7:11057
Kaempfer, Raymond; Popugailo, Andrey; Levy, Revital et al. (2017) Bacterial superantigen toxins induce a lethal cytokine storm by enhancing B7-2/CD28 costimulatory receptor engagement, a critical immune checkpoint. Receptors Clin Investig 4:
Molleston, Jerome M; Cherry, Sara (2017) Attacked from All Sides: RNA Decay in Antiviral Defense. Viruses 9:
Cifuentes-Muñoz, Nicolás; Sun, Weina; Ray, Greeshma et al. (2017) Mutations in the Transmembrane Domain and Cytoplasmic Tail of Hendra Virus Fusion Protein Disrupt Virus-Like-Particle Assembly. J Virol 91:
Sarute, Nicolás; Ross, Susan R (2017) New World Arenavirus Biology. Annu Rev Virol 4:141-158
Wahid, Rezwanul; Fresnay, Stephanie; Levine, Myron M et al. (2016) Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol 173:87-95
Li, Huiguang; Hwang, Young; Perry, Kay et al. (2016) Structure and Metal Binding Properties of a Poxvirus Resolvase. J Biol Chem 291:11094-104
Chou, Yi-Ying; Cuevas, Christian; Carocci, Margot et al. (2016) Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor. J Virol 90:4494-4510
Ramachandran, Girish; Tennant, Sharon M; Boyd, Mary A et al. (2016) Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella. PLoS One 11:e0151875

Showing the most recent 10 out of 375 publications